News

Igenica, Inc. secures $24 million in Series B financing
June 10, 2010

3-V Biosciences Appoints Edward M. Connor, Jr., MD, Chief Medical Officer
June 3, 2010

Constellation Pharmaceuticals Closes $22 Million in Series B Funding
June 2, 2010

3-V Biosciences Expands Leadership Team, Opens New Facility and Integrates Operations
May 13, 2010

Aragon Pharmaceuticals Secures $22 Million in Series B Financing
April 22, 2010

NGM Biopharmaceuticals Raises $51 Million in Series B Financing and Appoints New Board Member
March 15, 2010

PTC Therapeutics Closes $50 Million Financing
December 22, 2009

Constellation’s CSO and Scientific Advisor Receive Medal of Honor from American Cancer Society
November 23, 2009

The Column Group Announces Expansion of Investment Team - Names Magnus Persson Managing Partner
November 5, 2009

Aragon Pharmaceuticals’ Founder, Dr. Charles Sawyers Awarded 2009 Lasker-DeBakey Clinical Medical Research Award
October 27, 2009

NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, former Genentech CEO, to its Board of Directors
October 21, 2009

Constellation Pharmaceuticals Appoints Renowned Cancer Biologist Edward E. Harlow, Jr., Ph.D. as Company’s CSO
September 9, 2009

NGM Biopharmaceuticals Appoints Helen S. Kim as Chief Business Officer
September 1, 2009

Constellation Pharmaceuticals Appoints Mark A. Goldsmith, M.D., Ph.D. as CEO and Closes $17 Million in Funding
August 13, 2009

3-V Biosciences Secures $30 Million in Series B Funding, Welcomes New Members to Board of Directors
July 10, 2009

Aragon Pharmaceuticals Announces $8 Million Series A Financing
May 20, 2009

Igenica Appoints Dr. Mike Rothe as CEO After Closing Series A Financing
March 9th, 2009

IDRI and Immune Design Enter License Agreement on GLA Vaccine Adjuvant
November 20, 2008

FierceBiotech Names Constellation Pharmaceuticals as One of the “Fierce 15" Biotech Companies of 2008
June 24, 2008

Immune Design, Led By Star Scientists, Raises $18 Million To Build Vaccine Company
June 23, 2008

Constellation Pharmaceuticals Closes $32 Million in Series A Funding
April 29, 2008

NGM Biopharmaceuticals Raises $25.5M
February 12, 2008